{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-23-001846","form_type":"8-K","ticker":"LEXX","cik":"0001348362","company_name":"Lexaria Bioscience Corp.","filed_at":"2023-10-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.722120+00:00","generated_at":"2026-06-09T23:08:55.902427+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Lexaria grants exclusive global license to SulfoSyn for DehydraTECH-sulforaphane non-pharmaceutical products","bullets":["Up-front cash payment received; minimum future payments and ongoing royalties agreed.","Lexaria contracted for manufacturing at US partner facility for initial 2-year term.","DehydraTECH applied to sulforaphane, a compound with anti-inflammatory and antioxidant properties.","Non-pharmaceutical uses include supplements, additives, foods, and dietary ingredients.","SulfoSyn granted sub-licensing rights for the licensed technology."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-23-001846","json":"https://secwatch.observer/filing/0001640334-23-001846.json","markdown":"https://secwatch.observer/filing/0001640334-23-001846.md","text":"https://secwatch.observer/filing/0001640334-23-001846.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1348362/000164033423001846/0001640334-23-001846-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1348362/000164033423001846/lxrp_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T23:08:55.902427+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}